Medicine
Nebivolol 2.5 mg tablet
Nebivolol 2.5 mg tablet is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Nebivolol
- Brand
- Sold under the generic name
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 1 blister pack and 43 more
- Manufacturers
- Ascend LaboratoriesIndiaCadila PharmaceuticalsIndiaCamber PharmaceuticalsIndiaNovadoz PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaUnichem LaboratoriesIndiaAurobindo PharmaIndiaLifestar PharmaIndiaModavar Pharmaceuticals19 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C07AB12 Nebivolol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 April 2015
- Identifiers
- RxCUI 387013, 751612, 751618 +1DailyMed set ID b1762bbb-b5be-48a7-8101-bb736f28845a, 202d5142-6180-4d48-9a9f-1bd6992fc49b, b6c5abdd-bc2d-4ed6-8ca2-8a94c406ed0e +16NDC 29300-375, 31722-585, 33342-457 +16Application ANDA213830, ANDA203825, ANDA212661 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 19 labelers. The register lists 46 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 67877-393-01 | Ascend LaboratoriesIndia | 16 September 2021 |
| 30 tablet in 1 bottle | 67877-393-30 | Ascend LaboratoriesIndia | 16 September 2021 |
| 1 blister pack in 1 carton / 10 tablet in 1 blister pack | 67877-393-33 | Ascend LaboratoriesIndia | 16 September 2021 |
| 90 tablet in 1 bottle | 67877-393-90 | Ascend LaboratoriesIndia | 16 September 2021 |
| 30 tablet in 1 bottle | 59651-137-30 | Aurobindo PharmaIndia | 19 February 2025 |
| 90 tablet in 1 bottle | 59651-137-90 | Aurobindo PharmaIndia | 19 February 2025 |
| 30 tablet in 1 bottle | 71209-058-01 | Cadila PharmaceuticalsIndia | 16 October 2018 |
| 90 tablet in 1 bottle | 71209-058-04 | Cadila PharmaceuticalsIndia | 16 October 2018 |
| 100 tablet in 1 bottle | 71209-058-05 | Cadila PharmaceuticalsIndia | 16 October 2018 |
| 1000 tablet in 1 bottle | 71209-058-11 | Cadila PharmaceuticalsIndia | 16 October 2018 |
| 100 tablet in 1 bottle | 31722-585-01 | Camber PharmaceuticalsIndia | 17 September 2021 |
| 30 tablet in 1 bottle | 31722-585-30 | Camber PharmaceuticalsIndia | 17 September 2021 |
| 12 blister pack in 1 carton / 10 tablet in 1 blister pack | 31722-585-32 | Camber PharmaceuticalsIndia | 17 September 2021 |
| 15 blister pack in 1 carton / 10 tablet in 1 blister pack | 31722-585-34 | Camber PharmaceuticalsIndia | 17 September 2021 |
| 100 tablet in 1 bottle | 68462-615-01 | Glenmark PharmaceuticalsIndia | 25 May 2017 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 68462-615-11 | Glenmark PharmaceuticalsIndia | 25 May 2017 |
| 30 tablet in 1 bottle | 68462-615-30 | Glenmark PharmaceuticalsIndia | 25 May 2017 |
| 30 tablet in 1 bottle | 70756-025-30 | Lifestar PharmaIndia | 14 November 2022 |
| 30 tablet in 1 bottle | 33342-457-07 | Macleods PharmaceuticalsIndia | 29 January 2025 |
| 90 tablet in 1 bottle | 33342-457-10 | Macleods PharmaceuticalsIndia | 29 January 2025 |
| 12 blister pack in 1 carton / 10 tablet in 1 blister pack | 33342-457-25 | Macleods PharmaceuticalsIndia | 29 January 2025 |
| 30 tablet in 1 bottle | 72205-150-30 | Novadoz PharmaceuticalsIndia | 22 November 2024 |
| 90 tablet in 1 bottle | 72205-150-90 | Novadoz PharmaceuticalsIndia | 22 November 2024 |
| 100 tablet in 1 bottle | 72205-150-91 | Novadoz PharmaceuticalsIndia | 22 November 2024 |
| 100 tablet in 1 box, unit-dose | 72205-150-99 | Novadoz PharmaceuticalsIndia | 22 November 2024 |
| 500 tablet in 1 bottle | 29300-375-05 | Unichem LaboratoriesIndia | 4 April 2022 |
| 30 tablet in 1 bottle | 29300-375-13 | Unichem LaboratoriesIndia | 4 April 2022 |
| 90 tablet in 1 bottle | 29300-375-19 | Unichem LaboratoriesIndia | 4 April 2022 |
| 30 tablet in 1 bottle | 62559-275-30 | ANI Pharmaceuticals | 17 September 2021 |
| 2300 tablet in 1 bottle | 62559-275-83 | ANI Pharmaceuticals | 17 September 2021 |
| 30 tablet in 1 bottle | 24689-159-01 | Apnar Pharma | 13 May 2024 |
| 90 tablet in 1 bottle | 24689-159-02 | Apnar Pharma | 13 May 2024 |
| 90 tablet in 1 bottle | 72241-032-04 | Modavar Pharmaceuticals | 18 December 2021 |
| 100 tablet in 1 bottle | 72241-032-05 | Modavar Pharmaceuticals | 18 December 2021 |
| 1000 tablet in 1 bottle | 72241-032-11 | Modavar Pharmaceuticals | 18 December 2021 |
| 30 tablet in 1 bottle | 72241-032-22 | Modavar Pharmaceuticals | 18 December 2021 |
| 30 tablet in 1 bottle | 43547-524-03 | Solco Healthcare | 14 February 2022 |
| 90 tablet in 1 bottle | 43547-524-09 | Solco Healthcare | 14 February 2022 |
| 500 tablet in 1 bottle | 43547-524-50 | Solco Healthcare | 14 February 2022 |
| 5 tablet in 1 bottle | 50090-5708-0 | A-S Medication Solutions | 23 September 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 17 December 2007 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Nebivolol 2.5 mg tablet.
Other strengths and forms of Nebivolol
Clinical summary
Nebivolol is a beta-adrenergic blocker indicated for the treatment of hypertension, to lower blood pressure. It is available as tablets for oral use. MedsAcross supplies Nebivolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NebivololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Bystolic prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need Nebivolol 2.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.